Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 14.26 M | $1.64 B | 100.00% | 14.10% |
| VANGUARD GROUP INC | 11/13/2024 | 10.00 M | $1.15 B | -0.59% | 9.89% |
| STATE STREET CORP | 11/14/2024 | 5.15 M | $593.19 M | 11.72% | 5.09% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 2.57 M | $296.64 M | 4.31% | 2.55% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.86 M | $214.75 M | -1.84% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.86 M | $213.77 M | 2.18% | 1.84% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.84 M | $212.20 M | 50.71% | 1.82% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.76 M | $203.32 M | 138.16% | 1.75% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.68 M | $193.02 M | -6.88% | 1.66% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.50 M | $172.59 M | -36.60% | 1.48% |
| MORGAN STANLEY | 11/14/2024 | 1.35 M | $155.48 M | -12.65% | 1.33% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 1.32 M | $151.70 M | 90.53% | 1.30% |
| DODGE & COX | 11/13/2024 | 1.29 M | $148.38 M | 0.55% | 1.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.02 M | $117.20 M | -10.19% | 1.01% |
| DSM CAPITAL PARTNERS LLC | 11/14/2024 | 944,154 | $108.79 M | -5.37% | 0.93% |
| BROWN ADVISORY INC | 11/13/2024 | 942,147 | $108.55 M | -5.33% | 0.93% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 939,000 | $108.19 M | -0.11% | 0.93% |
| BRAIDWELL LP | 11/14/2024 | 917,674 | $105.73 M | 20.90% | 0.91% |
| INVESCO LTD. | 11/12/2024 | 874,665 | $100.78 M | -30.48% | 0.87% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 858,250 | $98.89 M | -8.15% | 0.85% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 842,197 | $97.03 M | -3.34% | 0.83% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 819,968 | $94.48 M | 4.74% | 0.81% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 792,196 | $91.28 M | -18.43% | 0.78% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 763,355 | $87.95 M | 26.86% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 747,291 | $86.10 M | -0.69% | 0.74% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 11/14/2024 | 736,910 | $84.91 M | 12.31% | 0.73% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 718,226 | $82.75 M | -20.15% | 0.71% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/18/2024 | 689,986 | $79.50 M | -2.90% | 0.68% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 664,336 | $77.36 M | -17.83% | 0.66% |
| AMUNDI | 11/13/2024 | 656,695 | $73.33 M | 67.82% | 0.65% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 636,914 | $73.39 M | 2.42% | 0.63% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 623,588 | $71.85 M | 0.75% | 0.62% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 621,363 | $78.13 M | -8.63% | 0.61% |
| JUPITER ASSET MANAGEMENT LTD | 11/12/2024 | 582,789 | $67.15 M | 89.77% | 0.58% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 544,321 | $62.72 M | 25.55% | 0.54% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 529,260 | $60.98 M | -7.82% | 0.52% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 524,168 | $60.39 M | -27.31% | 0.52% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 523,632 | $60.33 M | 10.72% | 0.52% |
| FIERA CAPITAL CORP | 11/01/2024 | 516,801 | $59.55 M | -2.10% | 0.51% |
| IEQ CAPITAL, LLC | 11/14/2024 | 512,480 | $59.05 M | 1.26% | 0.51% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 510,089 | $58.77 M | -6.59% | 0.50% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 496,094 | $57.16 M | 20.07% | 0.49% |
| MACQUARIE GROUP LTD | 11/14/2024 | 492,190 | $56.71 M | 81.64% | 0.49% |
| CANDRIAM S.C.A. | 11/13/2024 | 483,241 | $55.68 M | 3.82% | 0.48% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 11/13/2024 | 462,147 | $53.25 M | -4.72% | 0.46% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 460,000 | $53.00 M | -6.31% | 0.46% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 420,748 | $48.48 M | 639.65% | 0.42% |
| SARISSA CAPITAL MANAGEMENT LP | 11/14/2024 | 410,483 | $47.30 B | 0.00% | 0.41% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 404,000 | $46.55 M | -1.29% | 0.40% |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 10/29/2024 | 387,282 | $44.62 M | 15.96% | 0.38% |
Neurocrine Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 802 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 14.26 M
VANGUARD GROUP INC: 10 M
STATE STREET CORP: 5.15 M
RENAISSANCE TECHNOLOGIES LLC: 2.57 M
Bellevue Group AG: 1.86 M
GEODE CAPITAL MANAGEMENT, LLC: 1.86 M
91.70% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 128.78 M shares in the last 24 months. This purchase volume represents approximately $17.44 B in transactions.